Global Cervical Dystonia Therapeutics Market Growth (Status and Outlook) 2025-2031

September 2025 | 80 pages | ID: G66CFFEB362AEN
LP Information

Abstracts

According to this study, the global Cervical Dystonia Therapeutics market size will reach US$ million by 2031.

Cervical dystonia (or spasmodic torticollis) is the most common form of focal or localized dystonia. Neurological in origin, it is characterized by muscular spasms that cause abnormal movements of the neck, head and sometimes the shoulders. The neck muscles may contract, twist, tremble, or remain blocked in one direction, resulting in an awkward and uncomfortable posture.

United States market for Cervical Dystonia Therapeutics is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Cervical Dystonia Therapeutics is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Cervical Dystonia Therapeutics is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Cervical Dystonia Therapeutics players cover Allergan, Eisai, Ipsen Pharma, Merz Pharma, US WorldMeds, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Cervical Dystonia Therapeutics Industry Forecast” looks at past sales and reviews total world Cervical Dystonia Therapeutics sales in 2024, providing a comprehensive analysis by region and market sector of projected Cervical Dystonia Therapeutics sales for 2025 through 2031. With Cervical Dystonia Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cervical Dystonia Therapeutics industry.

This Insight Report provides a comprehensive analysis of the global Cervical Dystonia Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Cervical Dystonia Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cervical Dystonia Therapeutics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cervical Dystonia Therapeutics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cervical Dystonia Therapeutics.

This report presents a comprehensive overview, market shares, and growth opportunities of Cervical Dystonia Therapeutics market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Botulinum Toxins
• Drug
• Other

Segmentation by Application:

• Hospital
• Clinic
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Allergan
• Eisai
• Ipsen Pharma
• Merz Pharma
• US WorldMeds

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Cervical Dystonia Therapeutics Market Size (2020-2031)
  2.1.2 Cervical Dystonia Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Cervical Dystonia Therapeutics by Country/Region (2020, 2024 & 2031)
2.2 Cervical Dystonia Therapeutics Segment by Type
  2.2.1 Botulinum Toxins
  2.2.2 Drug
  2.2.3 Other
2.3 Cervical Dystonia Therapeutics Market Size by Type
  2.3.1 Cervical Dystonia Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Cervical Dystonia Therapeutics Market Size Market Share by Type (2020-2025)
2.4 Cervical Dystonia Therapeutics Segment by Application
  2.4.1 Hospital
  2.4.2 Clinic
  2.4.3 Other
2.5 Cervical Dystonia Therapeutics Market Size by Application
  2.5.1 Cervical Dystonia Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Cervical Dystonia Therapeutics Market Size Market Share by Application (2020-2025)

3 CERVICAL DYSTONIA THERAPEUTICS MARKET SIZE BY PLAYER

3.1 Cervical Dystonia Therapeutics Market Size Market Share by Player
  3.1.1 Global Cervical Dystonia Therapeutics Revenue by Player (2020-2025)
  3.1.2 Global Cervical Dystonia Therapeutics Revenue Market Share by Player (2020-2025)
3.2 Global Cervical Dystonia Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 CERVICAL DYSTONIA THERAPEUTICS BY REGION

4.1 Cervical Dystonia Therapeutics Market Size by Region (2020-2025)
4.2 Global Cervical Dystonia Therapeutics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Cervical Dystonia Therapeutics Market Size Growth (2020-2025)
4.4 APAC Cervical Dystonia Therapeutics Market Size Growth (2020-2025)
4.5 Europe Cervical Dystonia Therapeutics Market Size Growth (2020-2025)
4.6 Middle East & Africa Cervical Dystonia Therapeutics Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Cervical Dystonia Therapeutics Market Size by Country (2020-2025)
5.2 Americas Cervical Dystonia Therapeutics Market Size by Type (2020-2025)
5.3 Americas Cervical Dystonia Therapeutics Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Cervical Dystonia Therapeutics Market Size by Region (2020-2025)
6.2 APAC Cervical Dystonia Therapeutics Market Size by Type (2020-2025)
6.3 APAC Cervical Dystonia Therapeutics Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Cervical Dystonia Therapeutics Market Size by Country (2020-2025)
7.2 Europe Cervical Dystonia Therapeutics Market Size by Type (2020-2025)
7.3 Europe Cervical Dystonia Therapeutics Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Cervical Dystonia Therapeutics by Region (2020-2025)
8.2 Middle East & Africa Cervical Dystonia Therapeutics Market Size by Type (2020-2025)
8.3 Middle East & Africa Cervical Dystonia Therapeutics Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL CERVICAL DYSTONIA THERAPEUTICS MARKET FORECAST

10.1 Global Cervical Dystonia Therapeutics Forecast by Region (2026-2031)
  10.1.1 Global Cervical Dystonia Therapeutics Forecast by Region (2026-2031)
  10.1.2 Americas Cervical Dystonia Therapeutics Forecast
  10.1.3 APAC Cervical Dystonia Therapeutics Forecast
  10.1.4 Europe Cervical Dystonia Therapeutics Forecast
  10.1.5 Middle East & Africa Cervical Dystonia Therapeutics Forecast
10.2 Americas Cervical Dystonia Therapeutics Forecast by Country (2026-2031)
  10.2.1 United States Market Cervical Dystonia Therapeutics Forecast
  10.2.2 Canada Market Cervical Dystonia Therapeutics Forecast
  10.2.3 Mexico Market Cervical Dystonia Therapeutics Forecast
  10.2.4 Brazil Market Cervical Dystonia Therapeutics Forecast
10.3 APAC Cervical Dystonia Therapeutics Forecast by Region (2026-2031)
  10.3.1 China Cervical Dystonia Therapeutics Market Forecast
  10.3.2 Japan Market Cervical Dystonia Therapeutics Forecast
  10.3.3 Korea Market Cervical Dystonia Therapeutics Forecast
  10.3.4 Southeast Asia Market Cervical Dystonia Therapeutics Forecast
  10.3.5 India Market Cervical Dystonia Therapeutics Forecast
  10.3.6 Australia Market Cervical Dystonia Therapeutics Forecast
10.4 Europe Cervical Dystonia Therapeutics Forecast by Country (2026-2031)
  10.4.1 Germany Market Cervical Dystonia Therapeutics Forecast
  10.4.2 France Market Cervical Dystonia Therapeutics Forecast
  10.4.3 UK Market Cervical Dystonia Therapeutics Forecast
  10.4.4 Italy Market Cervical Dystonia Therapeutics Forecast
  10.4.5 Russia Market Cervical Dystonia Therapeutics Forecast
10.5 Middle East & Africa Cervical Dystonia Therapeutics Forecast by Region (2026-2031)
  10.5.1 Egypt Market Cervical Dystonia Therapeutics Forecast
  10.5.2 South Africa Market Cervical Dystonia Therapeutics Forecast
  10.5.3 Israel Market Cervical Dystonia Therapeutics Forecast
  10.5.4 Turkey Market Cervical Dystonia Therapeutics Forecast
10.6 Global Cervical Dystonia Therapeutics Forecast by Type (2026-2031)
10.7 Global Cervical Dystonia Therapeutics Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Cervical Dystonia Therapeutics Forecast

11 KEY PLAYERS ANALYSIS

11.1 Allergan
  11.1.1 Allergan Company Information
  11.1.2 Allergan Cervical Dystonia Therapeutics Product Offered
  11.1.3 Allergan Cervical Dystonia Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Allergan Main Business Overview
  11.1.5 Allergan Latest Developments
11.2 Eisai
  11.2.1 Eisai Company Information
  11.2.2 Eisai Cervical Dystonia Therapeutics Product Offered
  11.2.3 Eisai Cervical Dystonia Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Eisai Main Business Overview
  11.2.5 Eisai Latest Developments
11.3 Ipsen Pharma
  11.3.1 Ipsen Pharma Company Information
  11.3.2 Ipsen Pharma Cervical Dystonia Therapeutics Product Offered
  11.3.3 Ipsen Pharma Cervical Dystonia Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Ipsen Pharma Main Business Overview
  11.3.5 Ipsen Pharma Latest Developments
11.4 Merz Pharma
  11.4.1 Merz Pharma Company Information
  11.4.2 Merz Pharma Cervical Dystonia Therapeutics Product Offered
  11.4.3 Merz Pharma Cervical Dystonia Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Merz Pharma Main Business Overview
  11.4.5 Merz Pharma Latest Developments
11.5 US WorldMeds
  11.5.1 US WorldMeds Company Information
  11.5.2 US WorldMeds Cervical Dystonia Therapeutics Product Offered
  11.5.3 US WorldMeds Cervical Dystonia Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 US WorldMeds Main Business Overview
  11.5.5 US WorldMeds Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Cervical Dystonia Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Cervical Dystonia Therapeutics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Botulinum Toxins
Table 4. Major Players of Drug
Table 5. Major Players of Other
Table 6. Cervical Dystonia Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Cervical Dystonia Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 8. Global Cervical Dystonia Therapeutics Market Size Market Share by Type (2020-2025)
Table 9. Cervical Dystonia Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Cervical Dystonia Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Cervical Dystonia Therapeutics Market Size Market Share by Application (2020-2025)
Table 12. Global Cervical Dystonia Therapeutics Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Cervical Dystonia Therapeutics Revenue Market Share by Player (2020-2025)
Table 14. Cervical Dystonia Therapeutics Key Players Head office and Products Offered
Table 15. Cervical Dystonia Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Cervical Dystonia Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Cervical Dystonia Therapeutics Market Size Market Share by Region (2020-2025)
Table 20. Global Cervical Dystonia Therapeutics Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Cervical Dystonia Therapeutics Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Cervical Dystonia Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Cervical Dystonia Therapeutics Market Size Market Share by Country (2020-2025)
Table 24. Americas Cervical Dystonia Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 25. Americas Cervical Dystonia Therapeutics Market Size Market Share by Type (2020-2025)
Table 26. Americas Cervical Dystonia Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Cervical Dystonia Therapeutics Market Size Market Share by Application (2020-2025)
Table 28. APAC Cervical Dystonia Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Cervical Dystonia Therapeutics Market Size Market Share by Region (2020-2025)
Table 30. APAC Cervical Dystonia Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 31. APAC Cervical Dystonia Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Cervical Dystonia Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Cervical Dystonia Therapeutics Market Size Market Share by Country (2020-2025)
Table 34. Europe Cervical Dystonia Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 35. Europe Cervical Dystonia Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Cervical Dystonia Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Cervical Dystonia Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 38. Middle East & Africa Cervical Dystonia Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Cervical Dystonia Therapeutics
Table 40. Key Market Challenges & Risks of Cervical Dystonia Therapeutics
Table 41. Key Industry Trends of Cervical Dystonia Therapeutics
Table 42. Global Cervical Dystonia Therapeutics Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global Cervical Dystonia Therapeutics Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global Cervical Dystonia Therapeutics Market Size Forecast by Type (2026-2031) & ($ millions)
Table 45. Global Cervical Dystonia Therapeutics Market Size Forecast by Application (2026-2031) & ($ millions)
Table 46. Allergan Details, Company Type, Cervical Dystonia Therapeutics Area Served and Its Competitors
Table 47. Allergan Cervical Dystonia Therapeutics Product Offered
Table 48. Allergan Cervical Dystonia Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Allergan Main Business
Table 50. Allergan Latest Developments
Table 51. Eisai Details, Company Type, Cervical Dystonia Therapeutics Area Served and Its Competitors
Table 52. Eisai Cervical Dystonia Therapeutics Product Offered
Table 53. Eisai Cervical Dystonia Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Eisai Main Business
Table 55. Eisai Latest Developments
Table 56. Ipsen Pharma Details, Company Type, Cervical Dystonia Therapeutics Area Served and Its Competitors
Table 57. Ipsen Pharma Cervical Dystonia Therapeutics Product Offered
Table 58. Ipsen Pharma Cervical Dystonia Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Ipsen Pharma Main Business
Table 60. Ipsen Pharma Latest Developments
Table 61. Merz Pharma Details, Company Type, Cervical Dystonia Therapeutics Area Served and Its Competitors
Table 62. Merz Pharma Cervical Dystonia Therapeutics Product Offered
Table 63. Merz Pharma Cervical Dystonia Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. Merz Pharma Main Business
Table 65. Merz Pharma Latest Developments
Table 66. US WorldMeds Details, Company Type, Cervical Dystonia Therapeutics Area Served and Its Competitors
Table 67. US WorldMeds Cervical Dystonia Therapeutics Product Offered
Table 68. US WorldMeds Cervical Dystonia Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. US WorldMeds Main Business
Table 70. US WorldMeds Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Cervical Dystonia Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cervical Dystonia Therapeutics Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Cervical Dystonia Therapeutics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Cervical Dystonia Therapeutics Sales Market Share by Country/Region (2024)
Figure 8. Cervical Dystonia Therapeutics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Cervical Dystonia Therapeutics Market Size Market Share by Type in 2024
Figure 10. Cervical Dystonia Therapeutics in Hospital
Figure 11. Global Cervical Dystonia Therapeutics Market: Hospital (2020-2025) & ($ millions)
Figure 12. Cervical Dystonia Therapeutics in Clinic
Figure 13. Global Cervical Dystonia Therapeutics Market: Clinic (2020-2025) & ($ millions)
Figure 14. Cervical Dystonia Therapeutics in Other
Figure 15. Global Cervical Dystonia Therapeutics Market: Other (2020-2025) & ($ millions)
Figure 16. Global Cervical Dystonia Therapeutics Market Size Market Share by Application in 2024
Figure 17. Global Cervical Dystonia Therapeutics Revenue Market Share by Player in 2024
Figure 18. Global Cervical Dystonia Therapeutics Market Size Market Share by Region (2020-2025)
Figure 19. Americas Cervical Dystonia Therapeutics Market Size 2020-2025 ($ millions)
Figure 20. APAC Cervical Dystonia Therapeutics Market Size 2020-2025 ($ millions)
Figure 21. Europe Cervical Dystonia Therapeutics Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Cervical Dystonia Therapeutics Market Size 2020-2025 ($ millions)
Figure 23. Americas Cervical Dystonia Therapeutics Value Market Share by Country in 2024
Figure 24. United States Cervical Dystonia Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Cervical Dystonia Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Cervical Dystonia Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Cervical Dystonia Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Cervical Dystonia Therapeutics Market Size Market Share by Region in 2024
Figure 29. APAC Cervical Dystonia Therapeutics Market Size Market Share by Type (2020-2025)
Figure 30. APAC Cervical Dystonia Therapeutics Market Size Market Share by Application (2020-2025)
Figure 31. China Cervical Dystonia Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Cervical Dystonia Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Cervical Dystonia Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Cervical Dystonia Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 35. India Cervical Dystonia Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Cervical Dystonia Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Cervical Dystonia Therapeutics Market Size Market Share by Country in 2024
Figure 38. Europe Cervical Dystonia Therapeutics Market Size Market Share by Type (2020-2025)
Figure 39. Europe Cervical Dystonia Therapeutics Market Size Market Share by Application (2020-2025)
Figure 40. Germany Cervical Dystonia Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 41. France Cervical Dystonia Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Cervical Dystonia Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Cervical Dystonia Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Cervical Dystonia Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Cervical Dystonia Therapeutics Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Cervical Dystonia Therapeutics Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Cervical Dystonia Therapeutics Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Cervical Dystonia Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Cervical Dystonia Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Cervical Dystonia Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Cervical Dystonia Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Cervical Dystonia Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Cervical Dystonia Therapeutics Market Size 2026-2031 ($ millions)
Figure 54. APAC Cervical Dystonia Therapeutics Market Size 2026-2031 ($ millions)
Figure 55. Europe Cervical Dystonia Therapeutics Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Cervical Dystonia Therapeutics Market Size 2026-2031 ($ millions)
Figure 57. United States Cervical Dystonia Therapeutics Market Size 2026-2031 ($ millions)
Figure 58. Canada Cervical Dystonia Therapeutics Market Size 2026-2031 ($ millions)
Figure 59. Mexico Cervical Dystonia Therapeutics Market Size 2026-2031 ($ millions)
Figure 60. Brazil Cervical Dystonia Therapeutics Market Size 2026-2031 ($ millions)
Figure 61. China Cervical Dystonia Therapeutics Market Size 2026-2031 ($ millions)
Figure 62. Japan Cervical Dystonia Therapeutics Market Size 2026-2031 ($ millions)
Figure 63. Korea Cervical Dystonia Therapeutics Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Cervical Dystonia Therapeutics Market Size 2026-2031 ($ millions)
Figure 65. India Cervical Dystonia Therapeutics Market Size 2026-2031 ($ millions)
Figure 66. Australia Cervical Dystonia Therapeutics Market Size 2026-2031 ($ millions)
Figure 67. Germany Cervical Dystonia Therapeutics Market Size 2026-2031 ($ millions)
Figure 68. France Cervical Dystonia Therapeutics Market Size 2026-2031 ($ millions)
Figure 69. UK Cervical Dystonia Therapeutics Market Size 2026-2031 ($ millions)
Figure 70. Italy Cervical Dystonia Therapeutics Market Size 2026-2031 ($ millions)
Figure 71. Russia Cervical Dystonia Therapeutics Market Size 2026-2031 ($ millions)
Figure 72. Egypt Cervical Dystonia Therapeutics Market Size 2026-2031 ($ millions)
Figure 73. South Africa Cervical Dystonia Therapeutics Market Size 2026-2031 ($ millions)
Figure 74. Israel Cervical Dystonia Therapeutics Market Size 2026-2031 ($ millions)
Figure 75. Turkey Cervical Dystonia Therapeutics Market Size 2026-2031 ($ millions)
Figure 76. Global Cervical Dystonia Therapeutics Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Cervical Dystonia Therapeutics Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Cervical Dystonia Therapeutics Market Size 2026-2031 ($ millions)